Search results
View the latest Johnson & Johnson (JNJ) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Jan 24, 2024 · Photo: Mario Tama/Getty Images. Johnson & Johnson JNJ -1.82% delivered another solid earnings report Tuesday. It wasn’t enough to soothe Wall Street. The company’s medical device business...
Last Price. US$146.97. Market Cap. US$353.7b. 7D. -5.0% 1Y. -4.8% Updated. 26 May, 2024. Data. Company Financials +. 22 Analysts. JNJ Stock Overview. Researches, develops, manufactures, and sells various products in the healthcare field worldwide. About the company. Rewards. Trading at 40.8% below our estimate of its fair value.
May 13, 2024 · Wall Street deal-making remains robust despite the Federal Reserve’s rate hikes since 2022 J&J on Monday rolled out a new bond deal to help fund a roughly $13 billion acquisition. Getty...
Ratings. Financials. Earnings. Dividends. Valuation. Growth. Profitability. Momentum. Peers. Options. Charting. 52 Week Range. 143.13 175.97. Day Range. 146.76 149.81. EPS (FWD) 10.66. PE (FWD)...
Jan 23, 2024 · Jan 23 (Reuters) - Johnson & Johnson (JNJ.N) on Tuesday reported quarterly results just above Wall Street expectations, helped by strong sales of its blockbuster psoriasis drug Stelara, which...
